Cantel Medical (CMD) Misses Q2 EPS by 6c

Cantel Medical (NYSE: CMD) reported Q2 EPS of $0.61, $0.06 worse than the analyst estimate of $0.67. Revenue for the quarter came in at $288.5 million versus the consensus estimate of $290.45 million.

For earnings history and earnings-related data on Cantel Medical (CMD) click here.

You May Also Be Interested In

• Klarna shares tumble on weak full-year revenue guidance
• Benchmark Reiterates Speculative Buy Rating on Nephros (NEPH) Following Strong Q2 Results
• Xylem names Andrea van der Berg as CFO, effective Sept. 2026